picotamide has been researched along with Diabetes Mellitus in 3 studies
picotamide: has anticoagulant & fibrinolytic properties; structure
Diabetes Mellitus: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fibrinogen levels were related to clinical and laboratory variables in 2,111 patients suffering from PVD." | 2.69 | Determinants of fibrinogen in an Italian population suffering from claudication. Lower fibrinogen in the south compared to middle and north of Italy. The ADEP Group. ( Basili, S; Iuliano, L; Longoni, A; Milani, M; Vieri, M; Violi, F, 1998) |
| "Picotamide is an antiplatelet drug with a dual inhibitory action." | 2.44 | A review of picotamide in the reduction of cardiovascular events in diabetic patients. ( Celestini, A; Violi, F, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Celestini, A | 1 |
| Violi, F | 3 |
| Criqui, M | 1 |
| Longoni, A | 2 |
| Castiglioni, C | 1 |
| Basili, S | 1 |
| Milani, M | 1 |
| Vieri, M | 1 |
| Iuliano, L | 1 |
1 review available for picotamide and Diabetes Mellitus
| Article | Year |
|---|---|
A review of picotamide in the reduction of cardiovascular events in diabetic patients.
Topics: Cardiovascular Diseases; Diabetes Mellitus; Humans; Phthalic Acids; Platelet Aggregation Inhibitors; | 2007 |
2 trials available for picotamide and Diabetes Mellitus
| Article | Year |
|---|---|
Relation between risk factors and cardiovascular complications in patients with peripheral vascular disease. Results from the A.D.E.P. study.
Topics: Adult; Aged; Cardiovascular Diseases; Cerebrovascular Disorders; Comorbidity; Diabetes Mellitus; Dis | 1996 |
Determinants of fibrinogen in an Italian population suffering from claudication. Lower fibrinogen in the south compared to middle and north of Italy. The ADEP Group.
Topics: Diabetes Mellitus; Double-Blind Method; Fibrinogen; Humans; Hyperlipidemias; Hypertension; Intermitt | 1998 |